These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2378 related items for PubMed ID: 12504691
1. Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema. Yamamoto T, Hitani K, Tsukahara I, Yamamoto S, Kawasaki R, Yamashita H, Takeuchi S. Am J Ophthalmol; 2003 Jan; 135(1):14-9. PubMed ID: 12504691 [Abstract] [Full Text] [Related]
3. Tomographic assessment of vitreous surgery for diabetic macular edema. Otani T, Kishi S. Am J Ophthalmol; 2000 Apr; 129(4):487-94. PubMed ID: 10764858 [Abstract] [Full Text] [Related]
6. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema. Kumagai K, Furukawa M, Ogino N, Larson E, Iwaki M, Tachi N. Retina; 2009 Apr; 29(4):464-72. PubMed ID: 19289987 [Abstract] [Full Text] [Related]
8. Vitrectomy for diabetic macular edema: effect of glycemic control (HbA(1c)), renal function (creatinine) and other local factors. Kojima T, Terasaki H, Nomura H, Suzuki T, Mori M, Ito Y, Miyake Y. Ophthalmic Res; 2003 Apr; 35(4):192-8. PubMed ID: 12815194 [Abstract] [Full Text] [Related]
10. [Vitrectomy for diabetic cystoid macular edema -- results of 72 cases]. Aboutable T, Kalvodova B. Klin Monbl Augenheilkd; 2005 Aug; 222(8):643-8. PubMed ID: 16118745 [Abstract] [Full Text] [Related]
11. Microstructural and hemodynamic changes in the fundus after pars plana vitrectomy for different vitreoretinal diseases. Li D, Chen H, Huang S, Jia B, Lu L, Fu J. Graefes Arch Clin Exp Ophthalmol; 2024 Jul; 262(7):1977-1992. PubMed ID: 37982887 [Abstract] [Full Text] [Related]
13. Systemic factors influence the prognosis of diabetic macular edema after pars plana vitrectomy with internal limiting membrane peeling. Yamada Y, Suzuma K, Kumagami T, Fujikawa A, Kitaoka T. Ophthalmologica; 2013 Jul; 229(3):142-6. PubMed ID: 23257613 [Abstract] [Full Text] [Related]
16. Surgical treatment for severe diabetic macular edema with massive hard exudates. Yang CM. Retina; 2000 Jul; 20(2):121-5. PubMed ID: 10783943 [Abstract] [Full Text] [Related]
17. Optic nerve atrophy after vitrectomy with indocyanine green-assisted internal limiting membrane peeling in diffuse diabetic macular edema. Adverse effect of ICG-assisted ILM peeling. Ando F, Yasui O, Hirose H, Ohba N. Graefes Arch Clin Exp Ophthalmol; 2004 Dec; 242(12):995-9. PubMed ID: 15592868 [Abstract] [Full Text] [Related]
19. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A. Retina; 2006 Dec; 26(9):999-1005. PubMed ID: 17151486 [Abstract] [Full Text] [Related]
20. Results of visual acuity and foveal thickness in diabetic macular edema after vitrectomy. Shimonagano Y, Makiuchi R, Miyazaki M, Doi N, Uemura A, Sakamoto T. Jpn J Ophthalmol; 2007 Dec; 51(3):204-9. PubMed ID: 17554483 [Abstract] [Full Text] [Related] Page: [Next] [New Search]